|
Efficacy of Some Biochemical Markers in Diagnosis of Spontaneous Bacterial Peritonitis
|
|
|
Incidence and Predictors of Heamatological Side Effects in Chronic HCV Egyptian Patients Treated With Pegylated Interferon and Ribavirin
|
|
|
Spontaneous Bacterial Peritonitis in Egyptian Cirrhotic Patients with Nucleotide-binding Oligomerization Domain Containing 2 (NOD2) Gene Variants
|
|
|
Assessment of Eight Non-Invasive Markers of Liver Fibrosis in Egyptian Patients with Chronic Hepatitis C
|
|
|
Serum Levels of Soluble Fas Ligand and Resistin as Predictors of Hepatitis C Virus- Related Hepatocellular Carcinoma
|
|
|
Bone Mineral Density in Non-Cirrhotic Patients with Chronic Hepatitis C
|
|
|
Prediction of relapse Among Chronic HCV Genotype 4 Patients Treated With PEG-IFN and Ribavirin
|
|
|
The association between model for End-stage liver diseases (MELD) and spontaneous bacterial peritonitis (SBP) in patients with liver cirrhosis
|
|
|
Evaluation of Rapid Oral HCV Antibody Test For Diagnosis Of HCV Infection
|
|
|
Predictors of Early Non Virological Response to Peginterferon Plus Ribavirin Combination Therapy For Egyptian Patients Infected With Hepatitis C Virus
|
|
|
EVALUATION OF HEPATITIS B VIRUS VACCINE IMMUNOGENICITY AMONG HAEMODIALYSIS PATIENTS.
|